Previous Article | Next Article ![]()
J Virol, July 1998, p. 5502-5509, Vol. 72, No. 7
Department of
Genetics1 and
Howard Hughes Medical
Institute,2 Duke University Medical Center,
Durham, North Carolina 27710
Received 20 January 1998/Accepted 26 March 1998
Although DNA binding sites specific for the Bel-1 and Tas
transcriptional activators, encoded, respectively, by the human and
simian foamy viruses, have been mutationally defined, they show little
evident sequence identity. As a result, the sequence determinants for
DNA binding by both Bel-1 and Tas have remained unclear. Here, we
report the use of a novel in vivo randomization and selection strategy
to identify a Tas DNA binding site consensus. This approach takes
advantage of the fact that Tas can effectively activate gene expression
in yeast cells via a Tas DNA binding site derived from the simian foamy
virus type 1 (SFV-1) internal promoter. The defined Tas DNA binding
site consensus extends over approximately 25 bp and contains a critical
core sequence of ~5 bp. Positions adjacent to this core sequence,
while clearly also subject to selection, show a significantly higher
level of sequence variation. Surprisingly, the wild-type SFV-1 internal
promoter Tas DNA binding site fails to conform to the consensus at
several positions. Further analysis demonstrated that the consensus
sequence bound Tas more effectively than did the wild-type sequence in vitro and could mediate an enhanced Tas response in vivo when substituted into the SFV-1 internal promoter context. These findings explain the limited sequence identity observed for mutationally defined
Tas or Bel-1 response elements and should facilitate the identification
of Tas DNA target sites located elsewhere in the SFV-1 genome.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Derivation and Functional Characterization of a Consensus DNA
Binding Sequence for the Tas Transcriptional Activator of Simian
Foamy Virus Type 1
*
Corresponding author. Mailing address: Howard Hughes
Medical Institute, Duke University Medical Center, Box 3025, Durham, NC
27710. Phone: (919) 684-3369. Fax: (919) 681-8979. E-mail: Culle002{at}mc.duke.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»